G
GDRX
Goodrx Holdings, Inc.
3.475
-0.005-0.14%Opening14:16 10/28 EDT
OPEN/PREV CLOSE3.460/3.480
TODAY RANGE3.445-3.495
VOL339.63K
MARKET CAP1.19B
52 WEEK RANGE1.770-3.990
AVG VOL (3M)1.31M
% TURNOVER0.10%
TURNOVER--
P/E (TTM)74.09
% RANGE1.44%
EPS(TTM)0.0469
P/E(FORWARD)45.79
P/B1.825
BVPS1.904
DIVIDEND--
P/S1.487
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP311.73M
SHARES OUTSTANDING341.15M
NEXT EARNINGS11/02-11/06
FREE FLOAT89.71M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
NASDAQ·20h ago
Icon PLC (ICLR) Q3 Earnings and Revenues Beat Estimates
Simply Wall St·10/12 22:25
3 Penny Stocks Trading Up To 66% Below Fair Value
Simply Wall St·10/02 13:20
What Did The Market Misjudge About GoodRx?
TipRanks·09/15 17:36
Bank of America Securities Sticks to Its Sell Rating for GoodRx Holdings (GDRX)
TipRanks·09/03 13:10
GoodRx launches Companion Family Plan
Simply Wall St·08/31 11:05
Promising Penny Stocks To Consider In August 2026
Dow Jones·08/21 15:17
GoodRx Holdings Is Maintained at Underweight by Barclays
Dow Jones·08/21 15:17
GoodRx Holdings Price Target Raised to $4.00/Share From $3.00 by Barclays
Benzinga·08/21 15:07
Barclays Maintains Underweight on GoodRx Holdings, Raises Price Target to $4
TipRanks·08/20 19:00
GoodRx price target raised to $4 from $3 at Barclays
Dow Jones·08/13 21:29
GoodRx Holdings Is Maintained at Neutral by UBS
Dow Jones·08/13 21:29
GoodRx Holdings Price Target Raised to $3.75/Share From $2.50 by UBS
Benzinga·08/13 21:20
UBS Maintains Neutral on GoodRx Holdings, Raises Price Target to $3.75
Same Industry
Name/Symbol
Change%
Price